Review investor-profile analysis, accreditation checks, suitability inputs, and supervisory approvals tested on Series 82.
Once the account can be documented, the next issue is whether the investor profile supports participation in the offering. Series 82 treats this as both a suitability and supervision topic. The representative must gather the customer’s financial facts, investment objectives, tax status, liquidity needs, portfolio concentration, and sophistication. Then the firm has to determine whether the relationship and the offering can be approved.
This section is where private placements stop looking like generic securities sales. Many private offerings involve illiquidity, resale restrictions, concentration risk, and higher information asymmetry. That means the customer’s ability to absorb risk and to understand the offering becomes central. The strongest exam answer is usually the one that recognizes that financial profile review is not a box-checking exercise. It determines whether the recommendation and the account relationship are defensible.
Supervisory approval matters for the same reason. The firm is expected to have a review process, not just a representative judgment.
A prospective investor meets an accredited-investor standard but has limited liquidity and a highly concentrated existing portfolio. What is the strongest Series 82 conclusion?
A. Accredited status alone resolves the suitability question
B. The firm still has to evaluate whether the offering fits the investor’s broader profile and supervisory approval standards
C. The firm must reject the account automatically
D. The investor may participate only if the offering is a PIPE
Answer: B. Series 82 distinguishes investor qualification from full recommendation analysis. Accredited status may matter, but the firm still has to evaluate profile fit, risk, concentration, and supervisory approval.